Prostate-specific antigen (PSA) and PSA density: Racial differences in men without prostate cancer

Journal of the National Cancer Institute

Volumn 89, Issue 2, 1997, Pages 134-138

  Henderson, R Jonathan ^a,b   Eastham, James A ^a,b   Culkin, Daniel J ^a,b,e   Kattan, Michael W ^d   Whatley, Terence ^a,b   Mata, John ^a,b   Venable, Dennis ^a,b   Sartor, Oliver ^a,c  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b OVERTON BROOKS VA MEDICAL CENTER   (United States)

^c LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER SURVIVAL; CELL DENSITY; DRUG BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MALE; PROSTATE BIOPSY; PROSTATE CANCER; RACE DIFFERENCE; SURVIVAL RATE; TUMOR VOLUME;

EID: 0031012788     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.2.134     Document Type: Article

References (17)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996 [See comment citation in Medline]. CA Cancer J Clin 1996;46:5-27.
2. Boring CC, Squires TS, Health CW Jr. Cancer statistics for African Americans. CA Cancer J Clin 1992;42:7-17.
3. Mebane C, Gibbs T, Horm J. Current status of prostate cancer in North American black males. J Natl Med Assoc 1990;82:782-8.
4. Morton RA Jr. Racial differences in adenocarcinoma of the prostate in North American men. Urology 1994;44:637-45.
5. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;145: 907-23.
6. Vijayakumar S, Karrison T, Weichselbaum RR, Chan S, Quadri SF, Awan AM. Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer. Cancer Epidemiol Biomarkers Prev 1992;1: 541-5.
7. Moul JW, Sesterhenn IA, Connelly RR, Douglas T, Srivastava S, Mostofi FK, et al. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. JAMA 1995;274:1277-81.
8. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men [see comment citation in Medline]. J Urol 1994;151:1283-90.
9. Brawer MK, Chetner MP, Beatie J, Buchner DM, Vessella RL, Lange PH. Screening for prostatic carcinoma with prostate specific antigen. J Urol 1992;147:841-5.
10. Partin AW, Carter HB, Chan DW, Epstein JI, Oesterling JE, Rock RC, et al. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol 1990;143:747-52.
11. Crawford ED, DeAntoni EP. PSA as a screening test for prostate cancer. Urol Clin North Am 1993;20:637-46.
12. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges [see comment citation in Medline]. JAMA 1993;270:860-4.
13. Oesterling JE, Kumamoto Y, Tsukamoto T, Girman CJ, Guess HA, Masumori N, et al. Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men. Br J Urol 1995;75:347-53.
14. Morgan TO, Jacobsen SJ, McCarthy WF, Jacobson DJ, McLeod DG, Moul JW. Age-specific reference ranges for serum prostate-specific antigen in black men [See comment citation in Medline]. N Engl J Med 1996;335: 304-10.
15. Benson MC, Whang IS, Pantuck A, Ring K, Kaplan SA, Olsson CA, et al. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992;147:815-6.
16. Brawer MK, Aramburu EA, Chen GL, Preston SD, Ellis WJ. The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostatic carcinoma [See comment citations in Medline]. J Urol 1993; 150(2 Pt 1):369-73.
17. Lookner DH, Crawford ED, Donohue RE, Miller GJ, Clark JE, Stark GL. Prostate specific antigen and prostate specific antigen density in cases of pathologically proven prostate cancer [abstract]. J Urol 1993;149:414A.